ANNXAnnexon, Inc.

ANNX Stock Price, Valuation & Chart | Annexon, Inc.

Compare

$3.410-0.19 (-5.28%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology

Overview Financials Dividends Ratios

ANNX Historical price chart

ANNX Key Stats

Market Capitalization558.70M

PE Ratio-2.8

EPS-1.22

Trading Volume5.11M

Today's High/Low3.56/3.36

Dividend Yield0.00

52 Week High/Low7.18/2.54

Shares Outstanding163.84M

ANNX Financial Statement

ANNX Analyst ratings

ANNX Analysis & performance metrics

ANNX Company profile

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q…

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates…

ANNX Management team

Name

Position

Shikhar Agarwal M.B.A.

Senior Vice President & Head of Commercial

Henk-Andre Kroon M.D.

Senior Vice President of Translational Medicine

Douglas E. Love Esq., J.D.CEO

Chief Executive Officer, President & Director

Ted Yednock Ph.D.

Executive Vice President, Chief Innovation Officer & Chairman of the Scientific Advisory Board

Jennifer Lew CPACFO

Executive Vice President, Chief Financial Officer & Corporate Secretary

Michael Overdorf M.B.A.

Executive Vice President & Chief Business Officer

Jamie Dananberg M.D.

Executive Vice President & Chief Medical Officer

Sunil Mehta Pharm.D.

Senior Vice President of Medical Affairs

Name

Position

Shikhar Agarwal M.B.A.

Senior Vice President & Head of Commercial

Henk-Andre Kroon M.D.

Senior Vice President of Translational Medicine

Douglas E. Love Esq., J.D.CEO

Chief Executive Officer, President & Director

Ted Yednock Ph.D.

Executive Vice President, Chief Innovation Officer & Chairman of the Scientific Advisory Board

Jennifer Lew CPACFO

Executive Vice President, Chief Financial Officer & Corporate Secretary

Michael Overdorf M.B.A.

Executive Vice President & Chief Business Officer

Jamie Dananberg M.D.

Executive Vice President & Chief Medical Officer

Sunil Mehta Pharm.D.

Senior Vice President of Medical Affairs

Management Team

Shikhar Agarwal M.B.A.

Senior Vice President & Head of Commercial

Henk-Andre Kroon M.D.

Senior Vice President of Translational Medicine

Douglas E. Love Esq., J.D.CEO

Chief Executive Officer, President & Director

Ted Yednock Ph.D.

Executive Vice President, Chief Innovation Officer & Chairman of the Scientific Advisory Board

Jennifer Lew CPACFO

Executive Vice President, Chief Financial Officer & Corporate Secretary

Michael Overdorf M.B.A.

Executive Vice President & Chief Business Officer

Jamie Dananberg M.D.

Executive Vice President & Chief Medical Officer

Sunil Mehta Pharm.D.

Senior Vice President of Medical Affairs

Management

Shikhar Agarwal M.B.A.

Senior Vice President & Head of Commercial

Henk-Andre Kroon M.D.

Senior Vice President of Translational Medicine

Douglas E. Love Esq., J.D.CEO

Chief Executive Officer, President & Director

Ted Yednock Ph.D.

Executive Vice President, Chief Innovation Officer & Chairman of the Scientific Advisory Board

Jennifer Lew CPACFO

Executive Vice President, Chief Financial Officer & Corporate Secretary

Michael Overdorf M.B.A.

Executive Vice President & Chief Business Officer

Jamie Dananberg M.D.

Executive Vice President & Chief Medical Officer

Sunil Mehta Pharm.D.

Senior Vice President of Medical Affairs

Total 8 executives

ANNX Frequently asked questions

What is Annexon, Inc. (ANNX) Stock Price?

Current stock price of Annexon, Inc. (ANNX) stock is $3.410. The stock price is -5.28% lower in the session. The intraday range can be seen from this page. Volume of Annexon, Inc. (ANNX) stock is 5.11M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Annexon, Inc. (ANNX) stock price going up or down today?

The stock price of Annexon, Inc. (ANNX) can change with earnings, company news, and overall market sentiment. Annexon, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Annexon, Inc. stock expensive at its current price?

Whether Annexon, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ANNX on this page is -2.80. EPS on this page is -1.22. Compare those figures with peers and growth expectations before deciding if the current Annexon, Inc. price is justified.

How has the stock price of Annexon, Inc. (ANNX) performed historically?

Historical performance for Annexon, Inc. (ANNX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ANNX reacted to past earnings and market events.

Should I buy Annexon, Inc. (ANNX) stock, at this price?

Buying Annexon, Inc. (ANNX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.